Who We Are

HyNetics™ is a limited liability company equally owned by Alfa Laval Biokinetics and HyClone and focused on the development and manufacture of single-use based process systems.

HyClone is a Fisher Scientific company, while Alfa Laval Biokinetics is part of the Life Sciences Division of Alfa Laval. HyNetics™ marries the design, engineering, process, fabrication, and installation prowess of Alfa Laval Biokinetics with HyClone’s disposables manufacturing, plastics technologies, and media expertise. Simply put, Alfa Laval Biokinetics brings the hardware pieces of the puzzle to the partnership while HyClone brings the consumables pieces. The parent companies have cultivated a very close working relationship in developing HyNetics™ products, with project teams composed of key individuals from both companies truly working as a team with common objectives.

HyNetics™ consumables product manufacturing occurs in HyClone’s cGMP, ISO 9001 certified facilities, while the system hardware components are fabricated under Alfa Laval Biokinetics project management at their own manufacturing locations or at approved fabricator sites. Both parent companies bring a wealth of industry experience to the venture, helping ensure that your needs will be met with the highest applicable levels of quality. With the combined resources of both parents, HyNetics™ can fully service its customers from both the systems and the consumables standpoints.

Parent Company Strengths

Alfa Laval Biokinetics Inc.

Alfa Laval Biokinetics is focused on the biotechnology, pharmaceutical, cosmaceutical and other FDA-regulated industries. Headquartered in Philadelphia, PA, in the midst of biopharmaceutical research and industrial activity, with branch engineering offices in Raleigh-Durham, NC and Emeryville, CA, and Puerto Rico, our industry-leading team of process technology and program management specialists provides single-point design responsibility, from pre-conceptual studies through preliminary design, detailed design, construction, validation, and start-up. These professional service offices have been fully integrated with our equipment-manufacturing group located in Toronto, Canada, giving us the capability to provide guaranteed turnkey and design-build solutions for biopharm process, utility, equipment, and facility requirements worldwide.

Our engineers are recognized in the industry for their technical expertise. They are current with industry standards and specialize in the design of high-purity and sterile process systems and critical utility systems. We have over 100 engineers and designers with backgrounds in process, automation, mechanical, electrical, architectural, HVAC, piping design, and CAD modeling who provide services such as:

• Facility master planning

• Conceptual and preliminary design

• Constructability reviews

• cGMP audits

• Value engineering

• Validation and start-up

• Process simulation and optimization

• High-purity water system design

We strive to improve design efficiency and reduce the timeframe of the design phase by developing and using innovative benchmarking strategies. We have developed proprietary productivity-enhancing, computer-based tools that achieve outstanding results. For design-build projects, the goal is to arrive at a transition point to construction and/or manufacturing as quickly as possible. Members of the design team join the “downstream” teams to ensure that the intent of the design is carried through fabrication, construction, and start-up.

For more information, visit our web site at www.alfalaval.com

HyClone Laboratories, Inc., a worldwide cell culture and bioprocess consumables supply leader, is a subsidiary of Fisher Scientific, and is headquartered in Logan, Utah. HyClone’s Logan locations include manufacturing facilities for sera, dry powdered media, large volume liquid media, process liquids, and disposable BioProcess Containers (BPCs), including HyNetics disposable products. Also in Logan are HyClone’s cell culture R&D, Design Engineering, and administration functions, and its main warehousing and distribution operations. Non-European international operations are managed from Logan.

Other North American facilities include an automated BPC manufacturing site in Novato, California and multiple blood collection and serum processing sites at abattoirs throughout the United States and Canada.

Global markets are serviced through serum processing sites in New Zealand and Australia and a liquid media and BPC production site in Cramlington, England. International sales and distribution offices and warehouses are located in Aalst, Belgium and Beijing, China. The Aalst office manages European operations.

HyClone is registered with the US Food and Drug Administration as a Class I Medical Device Manufacturer and operates in accordance with current Good Manufacturing Practice (cGMP) requirements as described in 21 CFR 829 et seq.  HyClone is also certified as an ISO 9001 supplier.

For more information, visit our web site at www.hyclone.com.

Back to Top